National Oxygen Limited has disclosed that it is not required to provide a disclosure of related party transactions on a consolidated basis for the financial year ended March 31, 2026. The company communicated this to BSE Limited, citing specific exemptions under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Regulatory Exemption Criteria

Under Regulation 15(2) of the SEBI (LODR) Regulations, 2015, certain corporate governance provisions do not apply to listed entities with a paid-up equity share capital not exceeding ₹10 crore and a net worth not exceeding ₹25 crore as on the last day of the previous financial year. Consequently, the company is exempt from the requirements of Regulation 23(9), which mandates the disclosure of related party transactions.

Financial Position as of March 31, 2025

The company's eligibility for this exemption is based on its financial position as per the audited financial statements for the year ended March 31, 2025. The key figures are detailed below:

The data confirms that both the paid-up equity share capital and the net worth are below the prescribed regulatory limits. Therefore, the provisions of Regulation 23(9) regarding the disclosure of related party transactions are not applicable to National Oxygen Limited for the specified period.

Future Compliance Undertaking

National Oxygen Limited has undertaken to comply with the relevant regulations within six months from the date the provisions become applicable. The company stated that should its financial metrics exceed the exemption thresholds in the future, it will adhere to the disclosure requirements mandated by the SEBI (LODR) Regulations.

National Oxygen Limited has reported its standalone audited financial results for the financial year ended March 31, 2026. The company posted a net profit of ₹183.66 lakh, a significant improvement from the net loss of ₹700.22 lakh recorded in the previous year ended March 31, 2025. This return to profitability was largely attributed to exceptional items recognized during the period.

Financial Performance Overview

For the full year, national oxygen recorded total income of ₹2371.90 lakh, a decrease from ₹4086.01 lakh in the corresponding previous period. Revenue from operations stood at ₹2296.12 lakh, down from ₹4058.18 lakh in FY25. The company reported other income of ₹75.77 lakh for the current financial year.

The financial results for the quarter ended March 31, 2026, showed a net loss of ₹178.15 lakh, compared to a loss of ₹259.40 lakh in the same quarter of the previous year. Total income for the quarter was ₹431.32 lakh, while revenue from operations was ₹396.59 lakh.

Exceptional Items and Operational Metrics

The company recognized exceptional items totaling ₹812.26 lakh during the financial year. According to the notes accompanying the financial results, this profit arose from the sale of Mathur commercial land spanning 5.60 acres. The sale, completed on July 24, 2025, fetched ₹8.30 crore, and the proceeds were utilized to settle term loans, thereby reducing financial liabilities.

Operational Expenses and Assets

Total expenses for the year amounted to ₹3000.49 lakh, lower than the ₹4786.23 lakh reported in the previous year. Key expense components included power and fuel costs at ₹1570.99 lakh and employee benefit expenses at ₹269.09 lakh. Depreciation and amortisation expenses were reported at ₹231.32 lakh.

As of March 31, 2026, the company's total assets stood at ₹2825.89 lakh, a decrease from ₹3109.76 lakh in the previous year. Non-current assets were valued at ₹2383.50 lakh, while current assets stood at ₹442.39 lakh. The total equity and liabilities were reported at ₹2825.89 lakh.

Board Decisions and Auditor Appointment

In addition to the financial results, the Board of Directors approved the appointment of R. Bala Subramanian as the internal auditor of the company for the financial year 2026-27. The appointment is effective from May 25, 2026. The statutory auditors, M/S. PSDY & Associates, issued an audit report with an unmodified opinion on the standalone financial statements for the year ended March 31, 2026.